These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 34268411)

  • 1. Exosomes derived from cyclic mechanical stretch-exposed bone marrow mesenchymal stem cells inhibit RANKL-induced osteoclastogenesis through the NF-κB signaling pathway.
    Xiao F; Zuo B; Tao B; Wang C; Li Y; Peng J; Shen C; Cui Y; Zhu J; Chen X
    Ann Transl Med; 2021 May; 9(9):798. PubMed ID: 34268411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical cord mesenchymal stem cell-derived exosomes act via the miR-1263/Mob1/Hippo signaling pathway to prevent apoptosis in disuse osteoporosis.
    Yang BC; Kuang MJ; Kang JY; Zhao J; Ma JX; Ma XL
    Biochem Biophys Res Commun; 2020 Apr; 524(4):883-889. PubMed ID: 32057365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
    Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosavin suppresses osteoclastogenesis
    Zhang W; Zhang W; Huo L; Chai Y; Liu Z; Ren Z; Yu C
    Ann Transl Med; 2021 Mar; 9(5):383. PubMed ID: 33842604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK-estrogen receptor α signaling plays a role in the process of bone marrow mesenchymal stem cell-derived exosomes protecting against ovariectomy-induced bone loss.
    Qi H; Shen E; Shu X; Liu D; Wu C
    J Orthop Surg Res; 2023 Mar; 18(1):250. PubMed ID: 36973789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway.
    Guo H; Ding D; Wang L; Yan J; Ma L; Jin Q
    PLoS One; 2021; 16(12):e0261127. PubMed ID: 34914744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asiatic Acid Attenuates Osteoporotic Bone Loss in Ovariectomized Mice Through Inhibiting NF-kappaB/MAPK/ Protein Kinase B Signaling Pathway.
    Dong M; Zeng J; Yang C; Qiu Y; Wang X
    Front Pharmacol; 2022; 13():829741. PubMed ID: 35211021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
    Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Picroside II Inhibits RANKL-Mediated Osteoclastogenesis by Attenuating the NF-κB and MAPKs Signaling Pathway In Vitro and Prevents Bone Loss in Lipopolysaccharide Treatment Mice.
    Yang X; Gao W; Wang B; Wang X; Guo H; Xiao Y; Kong L; Hao D
    J Cell Biochem; 2017 Dec; 118(12):4479-4486. PubMed ID: 28464271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-2 ​T static magnetic field combined with Ferumoxytol prevent unloading-induced bone loss by regulating iron metabolism in osteoclastogenesis.
    Zhang G; Zhen C; Yang J; Zhang Z; Wu Y; Che J; Shang P
    J Orthop Translat; 2023 Jan; 38():126-140. PubMed ID: 36381248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of Jumonji domain-containing 1C inhibits the osteogenic differentiation of bone marrow mesenchymal stem cells
    Li JY; Wang TT; Ma L; Zhang Y; Zhu D
    World J Stem Cells; 2024 Feb; 16(2):151-162. PubMed ID: 38455099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
    Wang L; Zhao R; Shi X; Wei T; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
    Bone; 2009 Aug; 45(2):309-20. PubMed ID: 19379851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M2 macrophages-derived exosomes regulate osteoclast differentiation by the CSF2/TNF-α axis.
    Zhou Y; Hu G
    BMC Oral Health; 2024 Jan; 24(1):107. PubMed ID: 38238696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactin suppresses osteoclastogenesis via the NF-κB signaling pathway, promotes osteogenic differentiation in vitro, and inhibits oestrogen deficiency-induced bone loss in vivo.
    Kuang Z; Yang X; Cao Z; Li Y; Hu J; Hong X; Li B; Wu C; Qi Q; Liu X; Dai M
    Int Immunopharmacol; 2023 Apr; 117():109884. PubMed ID: 36805201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IFN-γ Antibody Promotes Osteoclastogenesis in Human Bone Marrow Monocyte-Derived Macrophages Co-Cultured with Tuberculosis-Activated Th1 Cells.
    Deng J; Sun D; Luo F; Zhang Q; Chen F; Xu J; Zhang Z
    Cell Physiol Biochem; 2018; 49(4):1512-1522. PubMed ID: 30205409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes derived from miRNA-210 overexpressing bone marrow mesenchymal stem cells protect lipopolysaccharide induced chondrocytes injury via the NF-κB pathway.
    He L; Chen Y; Ke Z; Pang M; Yang B; Feng F; Wu Z; Liu C; Liu B; Zheng X; Wu T; Shu T
    Gene; 2020 Aug; 751():144764. PubMed ID: 32428694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of Osteoporotic Activity by Endothelial Cell-Secreted Bone Targeting and Biocompatible Exosomes.
    Song H; Li X; Zhao Z; Qian J; Wang Y; Cui J; Weng W; Cao L; Chen X; Hu Y; Su J
    Nano Lett; 2019 May; 19(5):3040-3048. PubMed ID: 30968694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMSC-Derived Exosomes Ameliorate Osteoarthritis by Inhibiting Pyroptosis of Cartilage via Delivering miR-326 Targeting HDAC3 and STAT1//NF-
    Xu H; Xu B
    Mediators Inflamm; 2021; 2021():9972805. PubMed ID: 34764819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.